Li L, Leedom T, Do J, Huang H, Lai J, Johnson K
Transl Oncol. 2011; 4(4):249-57.
PMID: 21804921
PMC: 3140013.
DOI: 10.1593/tlo.11136.
Subramanian P, Crawford S, Becerra S
Methods Enzymol. 2011; 499:183-204.
PMID: 21683255
PMC: 3602996.
DOI: 10.1016/B978-0-12-386471-0.00010-9.
Staton C, Reed M, Brown N
Int J Exp Pathol. 2009; 90(3):195-221.
PMID: 19563606
PMC: 2697546.
DOI: 10.1111/j.1365-2613.2008.00633.x.
Mirochnik Y, Aurora A, Schulze-Hoepfner F, Deabes A, Shifrin V, Beckmann R
Clin Cancer Res. 2009; 15(5):1655-63.
PMID: 19223494
PMC: 2854536.
DOI: 10.1158/1078-0432.CCR-08-2113.
Nelius T, Filleur S, Yemelyanov A, Budunova I, Shroff E, Mirochnik Y
Int J Cancer. 2007; 121(5):999-1008.
PMID: 17487836
PMC: 2810747.
DOI: 10.1002/ijc.22802.
Local delivery of a synthetic endostatin fragment for the treatment of experimental gliomas.
Pradilla G, Legnani F, Petrangolini G, Francescato P, Chillemi F, Tyler B
Neurosurgery. 2005; 57(5):1032-40.
PMID: 16284573
PMC: 1635009.
DOI: 10.1227/01.neu.0000180059.33665.c1.
Nuclear factor of activated T cells balances angiogenesis activation and inhibition.
Zaichuk T, Shroff E, Emmanuel R, Filleur S, Nelius T, Volpert O
J Exp Med. 2004; 199(11):1513-22.
PMID: 15184502
PMC: 2211785.
DOI: 10.1084/jem.20040474.
Inhibition of rat corneal angiogenesis by a nuclease-resistant RNA aptamer specific for angiopoietin-2.
White R, Shan S, Rusconi C, Shetty G, Dewhirst M, Kontos C
Proc Natl Acad Sci U S A. 2003; 100(9):5028-33.
PMID: 12692304
PMC: 154292.
DOI: 10.1073/pnas.0831159100.
Low content of the natural ocular anti-angiogenic agent pigment epithelium-derived factor (PEDF) in aqueous humor predicts progression of diabetic retinopathy.
Boehm B, Lang G, Volpert O, Jehle P, Kurkhaus A, Rosinger S
Diabetologia. 2003; 46(3):394-400.
PMID: 12687338
DOI: 10.1007/s00125-003-1040-9.
Selective inhibition of vascular endothelial growth factor-mediated angiogenesis by cyclosporin A: roles of the nuclear factor of activated T cells and cyclooxygenase 2.
Hernandez G, Volpert O, Iniguez M, Lorenzo E, Martinez-Martinez S, Grau R
J Exp Med. 2001; 193(5):607-20.
PMID: 11238591
PMC: 2193389.
DOI: 10.1084/jem.193.5.607.
Histidine-rich glycoprotein inhibits the antiangiogenic effect of thrombospondin-1.
Simantov R, Febbraio M, Crombie R, Asch A, Nachman R, Silverstein R
J Clin Invest. 2001; 107(1):45-52.
PMID: 11134179
PMC: 198540.
DOI: 10.1172/JCI9061.
Smad4/DPC4-mediated tumor suppression through suppression of angiogenesis.
Schwarte-Waldhoff I, Volpert O, Bouck N, Sipos B, Hahn S, Klein-Scory S
Proc Natl Acad Sci U S A. 2000; 97(17):9624-9.
PMID: 10944227
PMC: 16915.
DOI: 10.1073/pnas.97.17.9624.
An in vivo function for the transforming Myc protein: elicitation of the angiogenic phenotype.
Ngo C, Gee M, Akhtar N, Yu D, Volpert O, Auerbach R
Cell Growth Differ. 2000; 11(4):201-10.
PMID: 10775037
PMC: 1635548.
Fisp12/mouse connective tissue growth factor mediates endothelial cell adhesion and migration through integrin alphavbeta3, promotes endothelial cell survival, and induces angiogenesis in vivo.
Babic A, Chen C, Lau L
Mol Cell Biol. 1999; 19(4):2958-66.
PMID: 10082563
PMC: 84090.
DOI: 10.1128/MCB.19.4.2958.
Inhibition of angiogenesis by interleukin 4.
Volpert O, Fong T, Koch A, Peterson J, Waltenbaugh C, Tepper R
J Exp Med. 1998; 188(6):1039-46.
PMID: 9743522
PMC: 2212547.
DOI: 10.1084/jem.188.6.1039.
CYR61, a product of a growth factor-inducible immediate early gene, promotes angiogenesis and tumor growth.
Babic A, Kireeva M, Kolesnikova T, Lau L
Proc Natl Acad Sci U S A. 1998; 95(11):6355-60.
PMID: 9600969
PMC: 27701.
DOI: 10.1073/pnas.95.11.6355.
A human fibrosarcoma inhibits systemic angiogenesis and the growth of experimental metastases via thrombospondin-1.
Volpert O, Lawler J, Bouck N
Proc Natl Acad Sci U S A. 1998; 95(11):6343-8.
PMID: 9600967
PMC: 27689.
DOI: 10.1073/pnas.95.11.6343.
Inhibition of tumor angiogenesis using a soluble receptor establishes a role for Tie2 in pathologic vascular growth.
Lin P, Polverini P, Dewhirst M, Shan S, Rao P, Peters K
J Clin Invest. 1997; 100(8):2072-8.
PMID: 9329972
PMC: 508398.
DOI: 10.1172/JCI119740.
CD36 mediates the In vitro inhibitory effects of thrombospondin-1 on endothelial cells.
Dawson D, Pearce S, Zhong R, Silverstein R, Frazier W, Bouck N
J Cell Biol. 1997; 138(3):707-17.
PMID: 9245797
PMC: 2141641.
DOI: 10.1083/jcb.138.3.707.
Captopril inhibits angiogenesis and slows the growth of experimental tumors in rats.
Volpert O, Ward W, Lingen M, Chesler L, Solt D, Johnson M
J Clin Invest. 1996; 98(3):671-9.
PMID: 8698858
PMC: 507476.
DOI: 10.1172/JCI118838.
